Latest / Pricing Power Podcast with Fexingo: How Businesses Set Prices, Raise Margins, and Win Customers
How EpiPen Prices Sparked a Pricing Revolt
In 2016, Mylan faced a national firestorm over the EpiPen's price, which had risen from about $100 in 2007 to $608 by 2016. This episode examines why the company raised prices so aggressively, how a single product's pricing became a political issue, and what happened next—including a $465 million settlement and the rise of authorized generics. We also look at the broader dynamics of pricing life-saving drugs and how patient out-of-pocket costs can create a blind spot for pharma companies. Lucas and Luna dig into the specific numbers, the congressional hearings, and the lessons for…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.